Group leader and postdoc-positions - Translational RNA Biology (m/f/d)
at the Molecular Medicine Partnership Unit (MMPU)
as of now at the Department of Pediatric Oncology, Hematology and Immunology for the Molecular Medicine Partnership Unit (MMPU) wanted.
The MMPU is a joint venture between the Medical Faculty of the University of Heidelberg and the European Molecular Biology Laboratory (EMBL). Research in the MMPU focuses on diseases with a particular medical need. One MMPU hallmark is that it is staffed by both institutions and each research group is headed by two or more cooperating principal investigators.
- Job-ID: V000012669
- Field of application: Klinik Kinderheilkunde III (Onkologie, Hämatologie und Immunologie, Pneumologie)
- Location: Heidelberg
- Start date: as of now
- Job Category: Science and teaching
- Working hours: full-time (100%)
- Published: 15.04.2024
- Limitation:Temporary (12 months, deferment / extension is sought)
- Contract:TV-L
We are seeking for
a visionary group leader and post-doctoral scientists with experience in RNA biology and/ or data science who will play leading roles in the MMPU group “Translational RNA Biology” co-headed by Prof. Matthias Hentze from EMBL and Prof. Andreas Kulozik from the Department of Pediatric Oncology, Hematology and Immunology of the Medical Faculty.
Our team focuses on basic and translational aspects of RNA biology and is currently expanding project lines exploring the role of RNA-binding proteins (RBP) in osteosarcoma and other pediatric malignancies including their responses to pharmacological intervention.
We offer
- An exceptional scientific environment with full scientific access to EMBL and the Medical Faulty within a vibrant international campus with connectivity to the visionary Hopp-Children's Cancer Research Centre (KiTZ).
- Goal-oriented, individual training and development opportunities
- Working with the latest techniques / technical equipment
- Possibility of mobile working
- Flexible working hours within the framework of flextime
- Possibility of habilitation
- Possibility to publish scientifically is offered and supported
- Regular team meetings
- Interdisciplinary cooperation
- Collectively agreed remuneration, attractive company pension scheme (VBL)
- 30 days vacation
- Sustainable travel: job ticket
- Family-friendly working environment: cooperative arrangements for childcare, subsidy for child vacation care, advice for employees with relatives in need of care
- Wide range of health, prevention and sports offers
Contact & Application
For further information please contact Andreas Kulozik or Matthias Hentze via e-mail (andreas.kulozik@med.uni-heidelberg.de or hentze@embl.org).
Interested?
Applications will be accepted until 05.05.2024 via e-mail.
Klinik Kinderheilkunde III (Onkologie, Hämatologie und Immunologie, Pneumologie)
Prof. Dr Andreas E.Kulozik
Im Neuenheimer Feld 430
69120 Heidelberg
Kinderonkologie.HD@med.uni-heidelberg.de
Note: The UKHD is subject to the provisions of the Infektionsschutzgesetz. Therefore, a valid measles immunity certificate is required for all persons employed at the UKHD.
The UKHD embraces diversity and values diversity.
Regardless of age, gender, sexual identity, disability, origin or religion, we offer everyone the same opportunities. If one gender is underrepresented in a particular area, we place particular emphasis on counteracting this imbalance. If they have the same aptitude, qualifications and professional performance, we give priority to people with severe disabilities when considering them for vacancies.
